vs
Side-by-side financial comparison of MEDICAL PROPERTIES TRUST INC (MPW) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
MEDICAL PROPERTIES TRUST INC is the larger business by last-quarter revenue ($270.3M vs $164.7M, roughly 1.6× PTC THERAPEUTICS, INC.). MEDICAL PROPERTIES TRUST INC runs the higher net margin — 6.5% vs -82.0%, a 88.5% gap on every dollar of revenue. On growth, MEDICAL PROPERTIES TRUST INC posted the faster year-over-year revenue change (16.6% vs -22.7%). Over the past eight quarters, MEDICAL PROPERTIES TRUST INC's revenue compounded faster (-0.2% CAGR vs -11.5%).
Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
MPW vs PTCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.3M | $164.7M |
| Net Profit | $17.6M | $-135.0M |
| Gross Margin | 95.8% | — |
| Operating Margin | 9.7% | -43.3% |
| Net Margin | 6.5% | -82.0% |
| Revenue YoY | 16.6% | -22.7% |
| Net Profit YoY | 104.3% | -104.8% |
| EPS (diluted) | $0.03 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.3M | $164.7M | ||
| Q3 25 | $237.5M | $211.0M | ||
| Q2 25 | $240.4M | $178.9M | ||
| Q1 25 | $223.8M | $1.2B | ||
| Q4 24 | $231.8M | $213.2M | ||
| Q3 24 | $225.8M | $196.8M | ||
| Q2 24 | $266.6M | $186.7M | ||
| Q1 24 | $271.3M | $210.1M |
| Q4 25 | $17.6M | $-135.0M | ||
| Q3 25 | $-77.7M | $15.9M | ||
| Q2 25 | $-98.4M | $-64.8M | ||
| Q1 25 | $-118.3M | $866.6M | ||
| Q4 24 | $-412.3M | $-65.9M | ||
| Q3 24 | $-801.2M | $-106.7M | ||
| Q2 24 | $-320.6M | $-99.2M | ||
| Q1 24 | $-875.6M | $-91.6M |
| Q4 25 | 95.8% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 91.8% | — | ||
| Q1 25 | 63.6% | — | ||
| Q4 24 | 90.9% | — | ||
| Q3 24 | 96.5% | — | ||
| Q2 24 | 98.4% | — | ||
| Q1 24 | 84.9% | — |
| Q4 25 | 9.7% | -43.3% | ||
| Q3 25 | -28.0% | 1.4% | ||
| Q2 25 | -36.7% | -19.5% | ||
| Q1 25 | -48.5% | 82.5% | ||
| Q4 24 | -173.7% | -76.2% | ||
| Q3 24 | -350.7% | -27.7% | ||
| Q2 24 | -114.5% | -21.5% | ||
| Q1 24 | -318.6% | -21.6% |
| Q4 25 | 6.5% | -82.0% | ||
| Q3 25 | -32.7% | 7.5% | ||
| Q2 25 | -40.9% | -36.3% | ||
| Q1 25 | -52.8% | 73.7% | ||
| Q4 24 | -177.8% | -30.9% | ||
| Q3 24 | -354.8% | -54.2% | ||
| Q2 24 | -120.3% | -53.1% | ||
| Q1 24 | -322.7% | -43.6% |
| Q4 25 | $0.03 | $-1.63 | ||
| Q3 25 | $-0.13 | $0.20 | ||
| Q2 25 | $-0.16 | $-0.83 | ||
| Q1 25 | $-0.20 | $10.04 | ||
| Q4 24 | $-0.68 | $-0.85 | ||
| Q3 24 | $-1.34 | $-1.39 | ||
| Q2 24 | $-0.54 | $-1.29 | ||
| Q1 24 | $-1.46 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $540.9M | $1.9B |
| Total DebtLower is stronger | $9.7B | — |
| Stockholders' EquityBook value | $4.6B | $-205.3M |
| Total Assets | $15.0B | $2.9B |
| Debt / EquityLower = less leverage | 2.11× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $540.9M | $1.9B | ||
| Q3 25 | $396.6M | $1.7B | ||
| Q2 25 | $509.8M | $2.0B | ||
| Q1 25 | $673.5M | $2.0B | ||
| Q4 24 | $332.3M | $1.1B | ||
| Q3 24 | $275.6M | $1.0B | ||
| Q2 24 | $606.5M | $1.1B | ||
| Q1 24 | $224.3M | $884.8M |
| Q4 25 | $9.7B | — | ||
| Q3 25 | $9.6B | — | ||
| Q2 25 | $9.6B | — | ||
| Q1 25 | $9.5B | — | ||
| Q4 24 | $8.8B | — | ||
| Q3 24 | $9.2B | — | ||
| Q2 24 | $9.4B | — | ||
| Q1 24 | $10.1B | — |
| Q4 25 | $4.6B | $-205.3M | ||
| Q3 25 | $4.7B | $-155.8M | ||
| Q2 25 | $4.8B | $-206.5M | ||
| Q1 25 | $4.8B | $-185.8M | ||
| Q4 24 | $4.8B | $-1.1B | ||
| Q3 24 | $5.4B | $-1.1B | ||
| Q2 24 | $6.2B | $-980.2M | ||
| Q1 24 | $6.7B | $-893.9M |
| Q4 25 | $15.0B | $2.9B | ||
| Q3 25 | $14.9B | $2.6B | ||
| Q2 25 | $15.2B | $2.6B | ||
| Q1 25 | $14.9B | $2.7B | ||
| Q4 24 | $14.3B | $1.7B | ||
| Q3 24 | $15.2B | $1.8B | ||
| Q2 24 | $16.2B | $1.9B | ||
| Q1 24 | $17.3B | $1.8B |
| Q4 25 | 2.11× | — | ||
| Q3 25 | 2.06× | — | ||
| Q2 25 | 2.00× | — | ||
| Q1 25 | 1.99× | — | ||
| Q4 24 | 1.83× | — | ||
| Q3 24 | 1.69× | — | ||
| Q2 24 | 1.51× | — | ||
| Q1 24 | 1.51× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $230.8M | $-34.3M |
| Free Cash FlowOCF − Capex | — | $-36.6M |
| FCF MarginFCF / Revenue | — | -22.3% |
| Capex IntensityCapex / Revenue | — | 1.4% |
| Cash ConversionOCF / Net Profit | 13.11× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $230.8M | $-34.3M | ||
| Q3 25 | $18.6M | $-66.3M | ||
| Q2 25 | $51.7M | $-58.3M | ||
| Q1 25 | $384.0K | $870.1M | ||
| Q4 24 | $245.5M | $-30.0M | ||
| Q3 24 | $59.2M | $-77.0M | ||
| Q2 24 | $35.3M | $-71.5M | ||
| Q1 24 | $74.3M | $70.8M |
| Q4 25 | — | $-36.6M | ||
| Q3 25 | — | $-69.7M | ||
| Q2 25 | — | $-59.6M | ||
| Q1 25 | — | $868.4M | ||
| Q4 24 | — | $-33.8M | ||
| Q3 24 | — | $-77.5M | ||
| Q2 24 | — | $-78.8M | ||
| Q1 24 | — | $61.2M |
| Q4 25 | — | -22.3% | ||
| Q3 25 | — | -33.1% | ||
| Q2 25 | — | -33.3% | ||
| Q1 25 | — | 73.8% | ||
| Q4 24 | — | -15.8% | ||
| Q3 24 | — | -39.4% | ||
| Q2 24 | — | -42.2% | ||
| Q1 24 | — | 29.1% |
| Q4 25 | — | 1.4% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 1.8% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 4.0% | ||
| Q1 24 | — | 4.6% |
| Q4 25 | 13.11× | — | ||
| Q3 25 | — | -4.17× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.00× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
